Prosecution Insights
Last updated: September 17, 2026
Application No. 18/264,706

METHOD FOR ESTIMATING THE MUSCLE PRESSURE OF A PATIENT BEING VENTILATED BY A PULMONARY VENTILATOR AND AUXILIARY DEVICE FOR A PULMONARY VENTILATOR

Non-Final OA §101§112
Filed
Aug 08, 2023
Priority
Feb 08, 2021 — nonprovisional of PCTBR2021050060
Examiner
SIPPEL, RACHEL T
Art Unit
3785
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Magnamed Tecnologia Médica S/A
OA Round
1 (Non-Final)
52%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
423 granted / 809 resolved
-17.7% vs TC avg
Strong +58% interview lift
Without
With
+58.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
40 currently pending
Career history
846
Total Applications
across all art units

Statute-Specific Performance

§101
4.2%
-35.8% vs TC avg
§103
49.2%
+9.2% vs TC avg
§102
15.3%
-24.7% vs TC avg
§112
26.4%
-13.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 809 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Amendment This office action is responsive to the preliminary amendment filed on 8/8/23. As directed by the amendment: claims 1-11 have been amended, no claims have been canceled, and no new claims have been added. Thus, claims 1-11 are presently pending in the application. Drawings The drawings are objected to because figures 1-9 have numbers and words that are illegible. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The disclosure is objected to because of the following informalities: Page 8, line 9 recites “Figures 5 to o” suggested to be changed to --Figures 5 to 9-- to correct a typographical error. Appropriate correction is required. Claim Objections Claims 1, 3-5 and 8 are objected to because of the following informalities: Claim 1 recites “the ventilator” in lines 5 and 10, suggested to be changed to --the pulmonary ventilator-- for consistency. Claim 1 recites “the time series points” in the last 2 lines, suggested to be changed to --the curve points-- for consistency. Claims 1 (lines 7-8 and 11) and 5 recite “the algorithm” suggested to be changed to --the predictive time-series algorithm-- for consistency. Claim 3, line 2, claim 4, lines 2-3 and claim 8, line 1 recites “a pulmonary ventilator” suggested to be changed to --the pulmonary ventilator-- in order to refer back to the recited pulmonary ventilator of claim 1. Claim 4, line 2 recites “a breathing simulator” suggested to be changed to --the breathing simulator-- in order to refer back to the recited breathing simulator of claim 3. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “the muscle pressure” in line 1, “the database” in line 2 and the muscle pressure value” in the last line, which lack proper antecedent basis. Claim 1, line 5 recites “the ventilator” suggested to be changed to --the pulmonary ventilator respiratory cycles-- for clarity. Claim 1, line 8 and claim 5, line 3 recite “a pulmonary ventilator” however it is unclear if applicant intends to refer back to the pulmonary ventilator or the pulmonary ventilator respiratory cycles. Claim 3 recites “muscles pressures” in line 4, however it is unclear if applicant is referring back to the muscle pressure from claim 1 or introducing new and different muscle pressures. Claim 5 recites “the populating step the algorithm with pressure” is confusing language that needs rephrasing. Claim 5 recites “a point,” “forty points” and “said points” however it is unclear if applicant is referring back to the curve points of claim 1 or introducing new and different points. Claim 5 recites “the pressure, volume and flow curves,” which lacks proper antecedent basis. Claim 6 recites “estimating points” however it is unclear if applicant is referring back to the curve points of claim 1 or points in claim 5 or introducing new and different points. Any remaining claims are rejected as being dependent on a rejected base claim. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-11 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. Each of Claims 1-11 have been analyzed to determine whether it is directed to any judicial exceptions. Step 2A, Prong 1 Each of Claims 1-11 recite at least one step for an estimating muscle pressure of a patient method, which is grouped as a mental process and mathematical concept under the 2019 PEG (see MPEP 2106.04(a)). Accordingly, each of Claims 1-11 recite an abstract idea. Specifically, independent Claim 1 recites (additional elements are in bold, abstract ideas are underlined): A method for estimating the muscle pressure of a patient being ventilated by a pulmonary ventilator, said method comprising: creating the database that correlates data on pressure, volume and flow of pulmonary ventilator respiratory cycles with muscle pressure data corresponding to said pressure, volume and flow data of the ventilator; using the database to create a training data set; training a predictive time-series algorithm with the training data set; populating the algorithm with pressure, volume and flow data from a pulmonary ventilator, the pressure, volume and flow data comprising at least one time series with pressure, volume and flow curve points generated by the ventilator; and using the algorithm to estimate the muscle pressure value for at least one of the time series points. The abstract ideas indicated by the underlined sections involve observation, judgment or evaluation, which is grouped as a mental process under the 2019 PEG. Accordingly, as indicated above, each of the above-identified claims recites an abstract idea. Further, dependent Claims 2-11 merely include limitations that either further define the abstract idea (and thus don’t make the abstract idea any less abstract) or amount to no more than generally linking the use of the abstract idea to a particular technological environment or field of use because they’re merely incidental or token additions to the claims that do not alter or affect how the process steps are performed. Specifically, Claim 2 recites (additional elements are in bold, abstract ideas are underlined): wherein the predictive time-series algorithm is an LSTM (Long Short-Term Memory) recurrent neural network. Specifically, Claim 3 recites (additional elements are in bold, abstract ideas are underlined): wherein the database covers data obtained with a pulmonary ventilator connected to a breathing simulator, the breathing simulator enabling the simulation of different resistance and elastance parameters and the introduction of muscle pressures having adjustable amplitude and duration. Specifically, Claim 4 recites (additional elements are in bold, abstract ideas are underlined): wherein the database covers data obtained with a breathing simulator and data obtained with a pulmonary ventilator in operation. Specifically, Claim 5 recites (additional elements are in bold, abstract ideas are underlined): wherein the populating step the algorithm with pressure, volume and flow data from a pulmonary ventilator comprises populating the data relating to a point, taken in a same time period, in each of the pressure, volume and flow curves and also forty points on each side of said points taken in the same time period. Specifically, Claim 6 recites (additional elements are in bold, abstract ideas are underlined): wherein the estimating step comprises estimating points of a muscle pressure curve. Specifically, Claim 7 recites (additional elements are in bold, abstract ideas are underlined): further comprising a post-processing step wherein a two-order Savitzky-Golay filter is applied to the muscle pressure curve. Specifically, Claim 8 recites (additional elements are in bold, abstract ideas are underlined): An auxiliary device for a pulmonary ventilator, comprising a device trained with the method defined in claim 1. Specifically, Claim 9 recites (additional elements are in bold, abstract ideas are underlined): wherein said device is connectable to the pulmonary ventilator. Specifically, Claim 10 recites (additional elements are in bold, abstract ideas are underlined): wherein said device is integrated to the pulmonary ventilator. Specifically, Claim 11 recites (additional elements are in bold, abstract ideas are underlined): wherein said device is integrated to a vital signs monitor. Step 2A, Prong 2 The above-identified abstract idea in the independent Claim 1 and its dependent Claims 2-11 are not integrated into a practical application under 2019 PEG because the additional elements (identified above in Claims 1-11), either alone or in combination, generally link the use of the above-identified abstract idea to a particular technological environment or field of use. More specifically, the additional elements of: pulmonary ventilator, breathing simulator, auxiliary device and vital signs monitor as recited in Claims 1, 3-5 and 9-11 do not serve to apply the above-identified abstract idea with, or by use of, a particular machine, effect a transformation or apply or use the above-identified abstract idea in some other meaningful way beyond generally linking the use thereof to a particular technological environment, such that the claim as a whole is more than a drafting effort designed to monopolize the exception. Furthermore, the above-identified additional elements do not add a meaningful limitation to the abstract idea because they amount to simply implementing the abstract idea on a computer. For at least these reasons, the abstract idea identified above in Claims 1-11 is not integrated into a practical application under 2019 PEG. Accordingly, independent Claim 1 and its dependent claims 2-11 are each directed to an abstract idea under 2019 PEG. Step 2B None of Claims 1-11 include additional elements that are sufficient to amount to significantly more than the abstract idea for at least the following reasons. These claims require the additional elements of: pulmonary ventilator, breathing simulator, auxiliary device and vital signs monitor as recited in Claims 11, 3-5 and 9-11. Taking the additional elements individually and in combination, the additional elements do not provide significantly more. Specifically, when viewed individually, the above-identified additional elements in Claims 1, 3-5 and 9-11 do not add significantly more because they are simply an attempt to limit the abstract idea to a particular technological environment. That is, neither the general computer elements nor any other additional element adds meaningful limitations to the abstract idea because these additional elements represent insignificant extra-solution activity. When viewed as a combination, these above-identified additional elements simply instruct the practitioner to implement the claimed functions with well-understood, routine and conventional activity specified at a high level of generality in a particular technological environment. As such, there is no inventive concept sufficient to transform the claimed subject matter into a patent-eligible application. As such, the above-identified additional elements, when viewed as whole, do not provide meaningful limitations to transform the abstract idea into a patent eligible application of the abstract idea such that the claims amount to significantly more than the abstract idea itself. Thus, Claims 1-11 merely apply an abstract idea to a computer and do not provide a technical solution to a problem in a technical field. Therefore, none of the Claims 1-11 amount to significantly more than the abstract idea itself. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Al-Rawas et al. (2012/0330177) directed towards a system and method for assessing real time pulmonary mechanics, Banner et al. (2014/0276173) directed towards methods and systems for monitoring resistance and work of breathing, Euliano et al. (2012/0215081) directed towards method and apparatus for predicting work of breathing, and Younes (2009/0221926) directed towards a method and device for generating of a signal that reflects respiratory effort. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RACHEL T SIPPEL whose telephone number is (571)270-1481. The examiner can normally be reached M-F 9:00-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Timothy Stanis can be reached at (571) 272-5139. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RACHEL T SIPPEL/Primary Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Aug 08, 2023
Application Filed
Aug 12, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12721773
INTERMETATARSAL SPACE VIBRATOR
3y 3m to grant Granted Sep 01, 2026
Patent 12721960
DEVICE FOR NASAL DELIVERY OF A FLUID PRODUCT
2y 8m to grant Granted Sep 01, 2026
Patent 12708728
TRACHEAL TUBE ASSEMBLY
3y 5m to grant Granted Aug 18, 2026
Patent 12702778
TRACHEOSTOMA DEVICE HOLDER
3y 8m to grant Granted Aug 11, 2026
Patent 12691235
CARTRIDGE UNIT COUPLER
5y 3m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
52%
Grant Probability
99%
With Interview (+58.3%)
3y 10m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 809 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month